Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XSCR capsule in acute ischemic stroke
NCT00710164Phase 3Unknown
- Sponsor
- Fudan University
- Start
- Sep 2008
- Primary completion
- Jul 2010
- Modality
- Traditional Chinese Medicine formulation
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in ischemic stroke comparing XSCR Capsule with Placebo (2 arms). Primary endpoint: Global disability on modified Rankin scale at 90 days. Status: unknown.
02
Drugs
Xiaoshuanchangrong
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT00710164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00710164.